These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


164 related items for PubMed ID: 3873988

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Acceleration of allogeneic antitumor immunity with immune RNA in vitro and T-cell suppression by L1210 tumor bearer spleen cells.
    Miura T, Maekawa T, Kurashige S, Mitsuhashi S.
    Cancer Res; 1981 Feb; 41(2):383-98. PubMed ID: 6160907
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Immunogenicity and amplifier cell production by tumor vaccines enhanced by concanavalin A.
    Kataoka T, Oh-Hashi F, Sakurai Y.
    Gan; 1982 Apr; 73(2):193-205. PubMed ID: 6811360
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Studies on the properties of a streptococcal preparation OK-432 (NSC-B116209) as an immunopotentiator. I. Activation of serum complement components and peritoneal exudate cells by group A streptococcus.
    Sakai S, Ryoyama K, Koshimura S, Migita S.
    Jpn J Exp Med; 1976 Apr; 46(2):123-33. PubMed ID: 778447
    [Abstract] [Full Text] [Related]

  • 12. Adjuvant activity of the cell wall of Bifidobacterium infantis for in vivo immune responses in mice.
    Sekine K, Watanabe-Sekine E, Toida T, Kasashima T, Kataoka T, Hashimoto Y.
    Immunopharmacol Immunotoxicol; 1994 Nov; 16(4):589-609. PubMed ID: 7876463
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Immunoprophylactic and immunotherapeutic response by concanavalin A-bound tumor vaccine enhanced by chemotherapeutic agents eliminating possible suppressors.
    Kataoka T, Ogihara K, Sakurai Y.
    Cancer Res; 1980 Oct; 40(10):3839-45. PubMed ID: 6449286
    [Abstract] [Full Text] [Related]

  • 15. Differential antigenic expression of the DBA/2 lymphoma L1210 and its sublines: cross-reactivity with C3H mammary tumors as defined by syngeneic monoclonal antibodies.
    Rapp L, Fuji H.
    Cancer Res; 1983 Jun; 43(6):2592-9. PubMed ID: 6342755
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Differential tumor immunogenicity of L1210 and its sublines. I. Effect of an increased antigen density on tumor cell surfaces on primary B cell responses in vitro.
    Fuji H, Mihich E, Pressman D.
    J Immunol; 1977 Sep; 119(3):983-6. PubMed ID: 330761
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Cyclophosphamide-induced appearance of immunopotentiating T-cells in the spleens of mice bearing a large MOPC-315 tumor.
    Ye QW, Mokyr MB.
    Cancer Res; 1984 Sep; 44(9):3873-9. PubMed ID: 6611201
    [Abstract] [Full Text] [Related]

  • 20. Mechanism of antitumor action of pyrimidinones in the treatment of B16 melanoma and P388 leukemia.
    Li LH, Wallace TL, Richard KA, Tracey DE.
    Cancer Res; 1985 Feb; 45(2):532-8. PubMed ID: 3967227
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.